What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Stroke
- Surgery
His primary scientific interests are in Stroke, Surgery, Internal medicine, Thrombolysis and Cardiology.
His Stroke study integrates concerns from other disciplines, such as Odds ratio, Randomized controlled trial and Stenosis.
His work deals with themes such as Radiology and Acute ischemic stroke, which intersect with Surgery.
His Thrombolysis research incorporates elements of Cerebral infarction, Clinical trial, Magnetic resonance imaging, Tissue plasminogen activator and Intracerebral hemorrhage.
His Cardiology research is multidisciplinary, incorporating perspectives in Diabetes mellitus and Vascular disease.
The study incorporates disciplines such as Anesthesia and Placebo in addition to Modified Rankin Scale.
His most cited work include:
- Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 (1793 citations)
- 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. (1234 citations)
- Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. (604 citations)
What are the main themes of his work throughout his whole career to date?
Peter A. Ringleb mostly deals with Stroke, Surgery, Internal medicine, Cardiology and Thrombolysis.
The various areas that Peter A. Ringleb examines in his Stroke study include Randomized controlled trial and Stenosis.
His research investigates the connection between Surgery and topics such as Radiology that intersect with issues in Neuroradiology.
Peter A. Ringleb has researched Thrombolysis in several fields, including Intracerebral hemorrhage, Cerebral infarction, Acute ischemic stroke and Emergency medicine.
His research integrates issues of Anesthesia, Blood pressure, Magnetic resonance imaging, Fibrinolytic agent and Cohort in his study of Modified Rankin Scale.
His Carotid endarterectomy study integrates concerns from other disciplines, such as Perioperative, Asymptomatic and Angioplasty.
He most often published in these fields:
- Stroke (60.98%)
- Surgery (36.86%)
- Internal medicine (35.77%)
What were the highlights of his more recent work (between 2018-2021)?
- Stroke (60.98%)
- Internal medicine (35.77%)
- Cardiology (25.47%)
In recent papers he was focusing on the following fields of study:
Peter A. Ringleb spends much of his time researching Stroke, Internal medicine, Cardiology, Thrombolysis and Modified Rankin Scale.
His Stroke study incorporates themes from Surgery and Stenosis.
His Cardiology research is multidisciplinary, relying on both Mortality rate, DUAL and Ischemic stroke.
His research in Thrombolysis tackles topics such as Acute ischemic stroke which are related to areas like Endovascular treatment and Radiology.
His studies deal with areas such as Anesthesia, Sedation, Vitamin K antagonist, Placebo and Intracerebral hemorrhage as well as Modified Rankin Scale.
His study looks at the intersection of Carotid endarterectomy and topics like Angioplasty with Carotid stenting.
Between 2018 and 2021, his most popular works were:
- Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data (123 citations)
- Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial. (102 citations)
- Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data (100 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Stroke
The scientist’s investigation covers issues in Stroke, Internal medicine, Modified Rankin Scale, Thrombolysis and Odds ratio.
Peter A. Ringleb works in the field of Stroke, namely Carotid stenting.
Peter A. Ringleb focuses mostly in the field of Internal medicine, narrowing it down to matters related to Cardiology and, in some cases, Ischemic stroke.
His Modified Rankin Scale research includes themes of Cohort study, Multivariate analysis, Adverse effect, Vitamin K antagonist and Placebo.
His study in Odds ratio is interdisciplinary in nature, drawing from both Meta-analysis, Anesthesia and Randomized controlled trial.
His research in Surgery intersects with topics in Stenosis and Angioplasty.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
